Spain – Various medicinal products – Suministro del principio activo denominado "BLINATUMOMAB 38,5 MCG VIAL POLVO INTRAV
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín awarded €115K to AMGEN, S.A. for Construction & Public Works in June 2026 — one of 265 awards this buyer has made, in line with its typical award size.
Winning supplier
AMGEN, S.A.Contract description
Spain – Various medicinal products – Suministro del principio activo denominado "BLINATUMOMAB 38,5 MCG VIAL POLVO INTRAVENOSA "para el Hospital Universitario de Gran Canaria Dr. Negrín.
Related awards · Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
265 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-199904-2026ACJ, S.A.U.€698K23 Mar 2026 Construction
- ocds-ted-37645-2025PALEX MEDICAL, S.A.€666K20 Jan 2025 Construction
- ocds-ted-497865-2024GETINGE GROUP SPAIN, S.L.U.€583K20 Aug 2024 Professional Services
Other wins · AMGEN, S.A.
68 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-625004-2025SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA€28.6M24 Sep 2025 Construction
- ocds-ted-468385-2026-1SERGAS. Servicio Gallego de Salud.€17.9M08 Jul 2026 Construction
- ocds-ted-421383-2025-2Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad€9.5M30 Jun 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín and AMGEN, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back